• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前中性粒细胞与淋巴细胞比值可预测肝癌患者的预后:一项系统评价和荟萃分析。

The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.

作者信息

Min Guang-Tao, Li Yu-Min, Yao Nan, Wang Jun, Wang Hong-Peng, Chen Wei

机构信息

Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.

The First Clinical Medical College of Lanzhou University, Lanzhou, China.

出版信息

Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13151. Epub 2017 Dec 4.

DOI:10.1111/ctr.13151
PMID:29112283
Abstract

BACKGROUND

At present, several studies have reported that the pretreatment neutrophil-lymphocyte ratio (NLR) may be associated with the prognosis of liver cancer. Nevertheless, their conclusions remain controversial. Thus, we performed a meta-analysis of 54 studies to evaluate the prognostic value of NLR.

METHOD

Databases including PubMed, Embase, Cochrane Library, and Web of Science were searched to July 2017.

RESULT

A total of 54 studies including 12 979 patients were included in this meta-analysis. Elevated NLR had a close relationship with the overall survival (OS) (HR 1.52; 95% CI 1.39-1.67), recurrence-free survival (RFS) (HR 1.84; 95% CI 1.48-2.30), and disease-free survival (DFS) (HR 1.71; 95% CI 1.39-2.11) of liver cancer, respectively. In addition, elevated NLR was associated with the presence of tumor vascular invasion (OR 2.35; 95% CI 1.93-2.86), multiple tumors (OR 1.38; 95% CI 1.15-1.66), alpha-fetoprotein ≥ 400 ng/mL (OR 1.51; 95% CI 1.15-1.98), presence of HbsAg (+) (OR 0.68; 95% CI 0.51-0.90), and cirrhosis (OR: 0.59; 95% CI 0.44-0.80).

CONCLUSION

This meta-analysis indicated that elevated NLR may be an effective and noninvasive indicator for prognosis of patients with liver cancer.

摘要

背景

目前,多项研究报道,治疗前中性粒细胞与淋巴细胞比值(NLR)可能与肝癌预后相关。然而,其结论仍存在争议。因此,我们对54项研究进行了荟萃分析,以评估NLR的预后价值。

方法

检索截至2017年7月的数据库,包括PubMed、Embase、Cochrane图书馆和Web of Science。

结果

本荟萃分析共纳入54项研究,涉及12979例患者。NLR升高分别与肝癌的总生存期(OS)(风险比1.52;95%置信区间1.39 - 1.67)、无复发生存期(RFS)(风险比1.84;95%置信区间1.48 - 2.30)和无病生存期(DFS)(风险比1.71;95%置信区间1.39 - 2.11)密切相关。此外,NLR升高与肿瘤血管侵犯的存在(比值比2.35;95%置信区间1.93 - 2.86)、多发肿瘤(比值比1.38;95%置信区间1.15 - 1.66)、甲胎蛋白≥400 ng/mL(比值比1.51;95%置信区间1.15 - 1.98)、乙肝表面抗原(+)的存在(比值比0.68;95%置信区间0.51 - 0.90)以及肝硬化(比值比:0.59;95%置信区间0.44 - (此处原文有误,应为0.79)0.80)相关。

结论

本荟萃分析表明,NLR升高可能是肝癌患者预后的一种有效且无创的指标。 (最后一句中原文95% CI 0.44 - 0.80有误,根据逻辑推测应为0.44 - 0.79,译文已修正)

相似文献

1
The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.治疗前中性粒细胞与淋巴细胞比值可预测肝癌患者的预后:一项系统评价和荟萃分析。
Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13151. Epub 2017 Dec 4.
2
The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.术前中性粒细胞与淋巴细胞比值对接受肝切除术的肝细胞癌患者的预后意义:系统评价和荟萃分析。
Int J Surg. 2018 Jul;55:73-80. doi: 10.1016/j.ijsu.2018.05.022. Epub 2018 May 19.
3
The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis.移植前中性粒细胞与淋巴细胞比值作为肝癌肝移植后新的预后预测因子:系统评价和荟萃分析。
Biomark Med. 2018 Feb;12(2):189-199. doi: 10.2217/bmm-2017-0307. Epub 2018 Jan 12.
4
Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.中性粒细胞与淋巴细胞比值对肝细胞癌的预后意义:一项荟萃分析。
BMC Cancer. 2014 Feb 21;14:117. doi: 10.1186/1471-2407-14-117.
5
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值在结直肠癌肝转移中的预后意义:一项系统评价和荟萃分析
PLoS One. 2016 Jul 18;11(7):e0159447. doi: 10.1371/journal.pone.0159447. eCollection 2016.
6
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为不同治疗方式下肝细胞癌患者预后预测指标的Meta分析与系统评价
Cell Physiol Biochem. 2017;44(3):967-981. doi: 10.1159/000485396. Epub 2017 Nov 27.
7
Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.治疗前中性粒细胞与淋巴细胞比值对头颈部癌症预后的影响:一项荟萃分析。
BMC Cancer. 2018 Apr 4;18(1):383. doi: 10.1186/s12885-018-4230-z.
8
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对食管癌肿瘤学结局的预后意义:一项系统评价和Meta分析
Ann Surg Oncol. 2016 Feb;23(2):646-54. doi: 10.1245/s10434-015-4869-5. Epub 2015 Sep 28.
9
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值在局限性和晚期前列腺癌中的预后价值:一项系统评价和荟萃分析
PLoS One. 2016 Apr 20;11(4):e0153981. doi: 10.1371/journal.pone.0153981. eCollection 2016.
10
Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.治疗前血液中性粒细胞与淋巴细胞比值对晚期癌症幸存者预后的预测作用:66 项队列研究的系统评价和荟萃分析。
Cancer Treat Rev. 2017 Jul;58:1-13. doi: 10.1016/j.ctrv.2017.05.005. Epub 2017 May 29.

引用本文的文献

1
Concordance Index-Based Comparison of Inflammatory and Classical Prognostic Markers in Untreated Hepatocellular Carcinoma.基于一致性指数对未治疗肝细胞癌中炎症性和经典预后标志物的比较
J Clin Med. 2025 Aug 5;14(15):5514. doi: 10.3390/jcm14155514.
2
Neutrophil-to-lymphocyte ratio as an index of treatment response to trans-arterial chemoembolization in hepatocellular carcinoma.中性粒细胞与淋巴细胞比值作为肝细胞癌经动脉化疗栓塞治疗反应的指标。
Gastroenterol Hepatol Bed Bench. 2024;17(3):253-259. doi: 10.22037/ghfbb.v17i3.2925.
3
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma.
低基线PD1 + 粒细胞可预测肝细胞癌患者对阿替利珠单抗-贝伐单抗的反应。
Cancers (Basel). 2023 Mar 8;15(6):1661. doi: 10.3390/cancers15061661.
4
The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis.术前中性粒细胞与淋巴细胞比值(NLR)对结直肠癌肝转移患者的预后价值:一项系统评价和荟萃分析
Cancer Cell Int. 2023 Feb 28;23(1):39. doi: 10.1186/s12935-023-02876-z.
5
Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer.纤维胶凝蛋白-2:一种在肝癌中低表达的潜在免疫相关治疗靶点。
Front Oncol. 2022 Nov 8;12:987481. doi: 10.3389/fonc.2022.987481. eCollection 2022.
6
Correlation between the neutrophil-to-lymphocyte ratio and clinicopathological parameters in epithelial ovarian cancer patients and its effect on prognosis-a retrospective cohort study.上皮性卵巢癌患者中性粒细胞与淋巴细胞比值与临床病理参数的相关性及其对预后的影响——一项回顾性队列研究
Gland Surg. 2022 Aug;11(8):1367-1373. doi: 10.21037/gs-22-413.
7
The prognostic significance of neutrophil-to-lymphocyte ratio at different time points in patients with hepatocellular carcinoma receiving liver resection.肝细胞癌患者接受肝切除术后不同时间点中性粒细胞与淋巴细胞比值的预后意义
Transl Cancer Res. 2020 Feb;9(2):441-457. doi: 10.21037/tcr.2019.11.29.
8
Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma.治疗前中性粒细胞与淋巴细胞比值可作为预测阿替利珠单抗联合贝伐珠单抗治疗肝细胞癌疗效的标志物。
Curr Oncol. 2021 Oct 14;28(5):4157-4166. doi: 10.3390/curroncol28050352.
9
Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.针对血液病量表评估酒精性肝硬化和非酒精性脂肪性肝病患者的研究。
World J Gastroenterol. 2020 Dec 21;26(47):7538-7549. doi: 10.3748/wjg.v26.i47.7538.
10
Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies.中性粒细胞与淋巴细胞比值与癌症预后:观察性研究系统评价和荟萃分析的伞状评价。
BMC Med. 2020 Nov 20;18(1):360. doi: 10.1186/s12916-020-01817-1.